全球放射肿瘤治疗计划软件市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球放射肿瘤治疗计划软件市场 – 行业趋势和 2030 年预测

  • Healthcare IT
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Radiation Oncology Treatment Planning Software Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 2.18 Billion
Diagram Market Size (Forecast Year)
USD 4.34 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球放射肿瘤治疗计划软件市场,按产品和服务(软件、患者信息系统、治疗计划系统、专业服务、咨询/优化服务、实施服务、售后和维护服务)、治疗类型(立体定向放射外科 (SRS)、3-D 适形放射治疗 (3D CRT)、近距离放射治疗、立体定向放射治疗 (SBRT)、调强放射治疗 (IMRT)、体积调强弧形治疗 (VMAT),其他,最终用户(医院和医生办公室、研究中心、政府机构、癌症治疗中心等)– 行业趋势和预测到 2030 年。 

放射肿瘤治疗计划软件市场

放射肿瘤治疗计划软件市场分析和规模

根据国际癌症研究机构的数据,肺癌发病率预计将从 2020 年的 221 万上升到 2030 年的 290 万。放射治疗用于治疗 NSCLC 和 SCLC,可单独使用或与化疗、术后或术前联合使用。近距离放射治疗用于治疗妇科、乳腺癌、肺癌、阴茎癌和其他类型的癌症。2020 年,用于治疗前列腺癌的 IBRT 占比最大。

Data Bridge Market Research 分析,放射肿瘤治疗计划软件市场在 2022 年为 21.8 亿美元,到 2030 年将飙升至 43.4 亿美元,预计在 2023 年至 2030 年的预测期内复合年增长率为 9.00%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

放射肿瘤治疗计划软件市场范围和细分  

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

产品和服务(软件、患者信息系统、治疗计划系统、专业服务、咨询/优化服务、实施服务、售后及维护服务)、治疗类型(立体定向放射外科 (SRS)、3-D 适形放射治疗 (3D CRT)、近距离放射治疗、立体定向放射治疗 (SBRT)、调强放射治疗 (IMRT)、容积调强弧形治疗 (VMAT)、其他、最终用户(医院和医生办公室、研究中心、政府机构、癌症治疗中心、其他)

覆盖国家

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

DOSIsoft SA (France), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), RaySearch Laboratories (Sweden), Elekta (Sweden), Brainlab AG (Germany), IBA Worldwide (Belgium), Accuray Incorporated (U.S.), VIEWRAY TECHNOLOGIES, INC. (U.S.), Varian Medical Systems, Inc. (U.K.), Institut Straumann AG (Switzerland), Nobel Biocare Services AG (Switzerland), CAMLOG Biotechnologies GmbH (U.S.), medentis medical GmbH (Germany), BEGO Medical GmbH (Germany), Dentsply Sirona. (U.S.), Zimmer Biomet (U.S.)

Market Opportunities

Market Definition

Radiation therapy for cancer patients is administered with radiation oncology treatment planning software. It can control radiations such as photons, FFF beams, electrons, low-dose-rate external beams for brachytherapy, protons, and cobalt treatment. The software decreases inter-planner variability, shortens planning times, and enhances patient-centered plan quality.

Global Radiation Oncology Treatment Planning Software Market Dynamics

Drivers

  • Rise in research and development activities

Market participants are focusing on research and development activities, which is driving market growth. For instance, Mayo Clinic and Google Health announced a joint initiative in October 2020 to conduct research into the application of artificial intelligence (AI) to radiation therapy planning, a critical component of cancer care. In a similar vein, Siris Medical, Inc. released new PlanMDTM software in 2018, allowing radiation oncology clinical teams to leverage patient data and artificial intelligence to empower their treatment decisions more efficiently. It is also the first and only tool that allows the physician to see the effect of contour editing in real-time, without the need for re-optimization or replanning.

  • Rising need for cutting-edge and efficient cancer treatments

The rising need for cutting-edge and efficient cancer treatments around the world, an increase in the number of cancer patients, and a sizable expenditure budget for them are the primary factors propelling the radiation oncology treatment planning software market. Furthermore, the fact that the software provides advanced care through beam planning and automated calculations and is significantly more accurate, quick, and efficient accelerates market growth from 2022 to 2030.

Opportunities

  • Increase in cancer treatment

推动治疗计划系统需求增长的另一个因素是软件调节辐射束的能力,例如质子、光子、FFF 束、电子、低剂量率近距离放射治疗外束和癌症治疗中的钴疗法。

推动市场发展的另一个驱动因素是质子治疗的接受度不断提高,因为这些射线越来越受癌症治疗的青睐。医疗和研究机构正在实施放射肿瘤治疗计划软件,以减少放射治疗对患者的附带组织损伤和负面影响,为市场参与者创造了机会。

限制/挑战

  • 成本高

预计高成本和规划和操作软件的熟练劳动力短缺将阻碍市场增长。此外,预测期内,发展中经济体的采用率较低可能会对放射肿瘤治疗规划软件市场构成挑战。

本放射肿瘤治疗计划软件市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关放射肿瘤治疗计划软件市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

全球放射肿瘤治疗计划软件市场范围

放射肿瘤治疗计划软件市场根据产品和服务、治疗类型和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

產品與服務

  • 软件
  • 病人信息系统
  • 治疗计划系统
  • 专业服务
  • 咨询/优化服务
  • 实施服务
  • 售后及维护服务

治疗类型

  • 立体定向放射外科 (SRS)
  • 三维适形放射治疗 (3D CRT)
  • 近距离放射治疗
  • 立体定向放射治疗 (SBRT)
  • 调强放射治疗 (IMRT)
  • 容积调强放射治疗 (VMAT)
  • 其他的

 终端用户

  • 医院和医生办公室
  • 研究中心
  • 政府机构
  • 癌症治疗中心
  • 其他的

放射肿瘤治疗计划软件市场区域分析/见解

对放射肿瘤治疗计划软件市场进行了分析,并按国家、产品和服务、治疗类型和最终用户提供了市场规模洞察和趋势。

放射肿瘤治疗计划软件市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于癌症患者数量较多以及癌症治疗提供中心和机构较多,北美在放射肿瘤治疗计划软件市场占据主导地位。

 由于放射疗法在癌症治疗中的应用日益广泛,预计亚太地区在 2023-2030 年的预测期内将实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值凯恩斯分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和放射肿瘤治疗计划软件市场份额分析

放射肿瘤治疗计划软件市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对放射肿瘤治疗计划软件市场的关注有关。

放射肿瘤治疗计划软件市场的一些主要参与者包括:

  • DOSIsoft SA(法国)
  • Koninklijke Philips NV(荷兰)
  • MIM Software Inc.(美国)
  • RaySearch 实验室(瑞典)
  • Elekta(瑞典)
  • Brainlab AG(德国)
  • IBA Worldwide(比利时)
  • Accuray Incorporated(美国)
  • VIEWRAY TECHNOLOGIES, INC.(美国)
  • 瓦里安医疗系统公司(英国)
  • Institut Straumann AG(瑞士)
  • Nobel Biocare Services AG(瑞士)
  • CAMLOG Biotechnologies GmbH(美国)
  • medentis Medical GmbH(德国)
  • BEGO Medical GmbH(德国)
  • Dentsply Sirona。(美国)
  • Zimmer Biomet(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Radiation Oncology Treatment Planning Software Market will be worth USD 4.34 billion in the forecast period by 2030.
The Radiation Oncology Treatment Planning Software Market growth rate is 9.00% during the forecast period.
Rise in research and development activities & Rising need for cutting-edge and efficient cancer treatments are the growth drivers of the Radiation Oncology Treatment Planning Software Market.
The products and services, therapy type and end-users are the factors on which the Radiation Oncology Treatment Planning Software Market research is based.
Major companies in the Radiation Oncology Treatment Planning Software Market are DOSIsoft SA (France), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), RaySearch Laboratories (Sweden), Elekta (Sweden), Brainlab AG (Germany), IBA Worldwide (Belgium), Accuray Incorporated (U.S.), VIEWRAY TECHNOLOGIES, INC. (U.S.), Varian Medical Systems, Inc. (U.K.), Institut Straumann AG (Switzerland), Nobel Biocare Services AG (Switzerland), CAMLOG Biotechnologies GmbH (U.S.), medentis medical GmbH (Germany), BEGO Medical GmbH (Germany), Dentsply Sirona. (U.S.), Zimmer Biomet (U.S.).